SCHEMBL5817196

SCHEMBL5817196

CN(C)CC(=O)N1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(NC4CC4)n3)s2)CC1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.52
KCNH2 Q12809 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5816278 0.87 EGFR (0.54) EGFRKCNH2
SCHEMBL5818495 0.87 EGFR (0.51) EGFRKCNH2
SCHEMBL5812854 0.85 EGFR (0.57) EGFRKCNH2
SCHEMBL5812894 0.85 EGFR (0.50) EGFRKCNH2
SCHEMBL5814596 0.85 KCNH2 (0.49) EGFRKCNH2
SCHEMBL5812181 0.84 KCNH2 (0.67) EGFRKCNH2
SCHEMBL5819187 0.84 EGFR (0.53) EGFRKCNH2
SCHEMBL5818905 0.84 EGFR (0.63) EGFRKCNH2
SCHEMBL5819594 0.83 EGFR (0.52) EGFRKCNH2
SCHEMBL5817130 0.82 EGFR (0.54) EGFRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed